ArticleInvestigational new drugs2020

Safety and efficacy of afatinib for the treatment of non-small-cell lung cancer following osimertinib-induced interstitial lung disease: A retrospective study.

Shingo Nasu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.